The FDA reported that the cause of the itching is currently unknown, although there are indications of a “causal relationship ...

Zyrtec is a brand-name over-the-counter (OTC) medication used to treat allergy symptoms. Zyrtec is not known to raise blood pressure, but it may depend on which form of the drug you take.

As of May 2025, the FDA issued an alert that discontinuing Zyrtec after long-term use may result in severe pruritus (or, itchiness) within a few days. It's rare, but can sometimes require medical ...

Just in time for allergy season, a recent FDA warning describes a new side effect for those who take Zyrtec or Xyzal long-term. This is what you should know.

Cetirizine and levocetirizine are both antihistamine drugs that have been around for a while. The former was first approved as the prescription drug Zyrtec in 1995, while levocetirizine was ...

The FDA notes that about 100 million prescriptions or OTC purchases of both drugs combined were made in 2022. People with the side effect aren’t necessarily doomed to itch forever, either.

The FDA reported finding 209 cases worldwide, between 2017 and 2023, in people who stopped using the two medications.

Two antihistamines, including Zyrtec, are under warning by the FDA after people reported “severe itching” after ceasing long-term use of the drugs—what to know.

by CNN/CNN Newsource Sat, May 24th 2025 at 3:32 PM (CNN/CNN Newsource) TOPICS: FDA Allergy medications Severe reaction Zyrtec Xyzal Warning Itching Long-term use ...

The U.S. Food and Drug Administration has issued a warning about a rare but severe reaction that can happen to people who stop taking oral allergy medicines like Zyrtec or Xyzal.

The U.S. Food and Drug Administration (FDA) issued an alert related to cetirizine (Zyrtec) or levocetirizine (Xyzal), warning that patients who stop taking it after long-term use may experience ...

Hundreds of people who stopped using allergy medications like Zyrtec and Xyzal noticed an uncomfortable new side effect, the U.S. Food and Drug Administration said in a warning issued this month ...